Cargando…

ASH Meeting 2016: developments in hemostaseology

During the annual meeting of the American Society of Hematology (ASH) in San Diego/California, novel developments in the field of hemostaseology were presented. Alternative treatment strategies besides factor replacement were discussed for patients with hemophilia. One of the highlights of the meeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feistritzer, Clemens, Mosheimer, Birgit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2017
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493715/ https://www.ncbi.nlm.nih.gov/pubmed/28725275 http://dx.doi.org/10.1007/s12254-017-0339-z

Ejemplares similares

Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015
por: Feistritzer, Clemens, et al.
Publicado: (2016)

Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9
por: Kaneider, Nicole C, et al.
Publicado: (2010)

Influencing Factors and Differences in Born Aggregometry in Specialized Hemostaseological Centers: Results of a Multicenter Laboratory Comparison
por: Kaiser, Thorsten, et al.
Publicado: (2022)

Methotrexate therapy impacts on red cell distribution width and its predictive value for cardiovascular events in patients with rheumatoid arthritis
por: Held, Julia, et al.
Publicado: (2018)

Chronic lymphocytic leukemia at ASH 2017
por: Wanner, David, et al.
Publicado: (2018)

Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin
por: Djanani, Angela, et al.
Publicado: (2006)

News in AL Amyloidosis ASH 2016: A rapidly evolving field of investigation
por: Agis, Hermine
Publicado: (2017)

Ashes to ashes: the history of smoking and health
por: Pyke, David
Publicado: (2000)

Immunomodulation by α(1)-proteinase inhibitor: lack of chemotactic effects of recombinant human α(1)-proteinase inhibitor from yeast on human peripheral blood granulocytes
por: Mosheimer, Birgit, et al.
Publicado: (2007)

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
por: Zhu, Xiongpeng, et al.
Publicado: (2010)

A versatile method for assessing pathogenicity of Hymenoscyphus fraxineus to ash foliage
por: Orton, Elizabeth S., et al.
Publicado: (2018)

Progress and trends in publication of oral and video presentations at the society of gynecologic oncology annual meeting from 2006 to 2016
por: Milki, Anthony A., et al.
Publicado: (2021)

Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting
por: Zhang, Kejie, et al.
Publicado: (2016)

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
por: Hou, Jing-Zhou, et al.
Publicado: (2021)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022)

Prevention of unintentional childhood injury: A review of study designs in the published literature 2013–2016
por: Rothman, Linda, et al.
Publicado: (2019)

The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90‐90‐90 targets
por: Keen, Phillip, et al.
Publicado: (2018)

Application of somatic embryogenesis for development of emerald ash borer-resistant white ash and green ash varietals
por: Merkle, Scott A., et al.
Publicado: (2022)

Aggressive lymphoma 2016: revision of the WHO classification
por: Beham-Schmid, Christine
Publicado: (2017)

ASCO 2016 – update colorectal liver metastases
por: Kaczirek, Klaus
Publicado: (2017)

Ash trays used to be standard equipment in all meeting rooms
por: CERN PhotoLab
Publicado: (1975)

SABCS 2016: systemic therapy for metastatic breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Meeting Abstracts - Annual Meeting 2016
Publicado: (2016)

Recent advances in myelodysplasia: update from 2011 ASH annual meeting
por: Liu, Delong
Publicado: (2012)

Reimagining Medical Education: Selected Abstracts From the 2020 ASH Meeting
por: Kurtin, Sandra E.
Publicado: (2021)

Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
por: Cao, Yang, et al.
Publicado: (2023)

MEETINGS CALENDAR - 2016
Publicado: (2016)

MEETINGS CALENDAR 2016
Publicado: (2016)

Physics meeting 2016
Publicado: (2016)

On the occasion of world kidney day 2016; work together to better protect the kidney
por: Nasri, Hamid, et al.
Publicado: (2016)

Incorporating Scientific Advances and Improving Access to Care: Meeting Abstracts From the 2021 ASH Annual Meeting and Exposition
por: Kurtin, Sandra E.
Publicado: (2022)

Ethylenediurea (EDU) Affects the Growth of Ozone-Sensitive and Tolerant Ash (Fraxinus excelsior) Trees under Ambient O(3) Conditions
por: Paoletti, Elena, et al.
Publicado: (2007)

Meeting report of the 2016 bone marrow adiposity meeting
por: van der Eerden, Bram, et al.
Publicado: (2017)

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
por: Hirsh, Vera, et al.
Publicado: (2017)

Tales from the Jazz ASH: highlights from the 2013 American Society of Haematology meeting
por: Mazzarella, Luca
Publicado: (2014)

Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting
por: Guo, Ruiting, et al.
Publicado: (2022)

Bioactivity and Biocompatibility Properties of Sustainable Wollastonite Bioceramics from Rice Husk Ash/Rice Straw Ash: A Review
por: Ismail, Hamisah, et al.
Publicado: (2021)

Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016
por: Suppan, Christoph, et al.
Publicado: (2017)

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017
por: Magnes, Teresa, et al.
Publicado: (2017)

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
por: Gulley, James L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_06bfs1n1uhprtls8n948ka1eo7